Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006326

CEO sold 5,990 shares at $3.34 ($19,995)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Sale : show line 1 in the form −5,990 $3.34 $19,995 1,046,055 D
Open-market sales · 5,990 sh · avg $3.34 · $19,995
Loading xslF345X05/form4.xml…